Xilio Therapeutics
XLO
#9617
Rank
A$63.34 M
Marketcap
$1.22
Share price
-5.23%
Change (1 day)
-23.05%
Change (1 year)

EPS for Xilio Therapeutics (XLO)

EPS in 2023 (TTM): -$4.60

According to Xilio Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.78. In 2022 the company made an earnings per share (EPS) of -$5.02 a decrease over its 2021 EPS that were of -$4.80.

EPS history for Xilio Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.60-8.24%
2022-$5.024.42%
2021-$4.80